Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results
30 juil. 2020 17h42 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer,...
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
13 juil. 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary
26 juin 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the...
Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum
22 juin 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
11 juin 2020 17h15 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020
14 mai 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Provides Corporate Update
02 avr. 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 02, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS
16 mars 2020 19h51 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 16, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer,...
Helix BioPharma Corp. Closes $6.0 Million Private Placement
12 mars 2020 17h05 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 12, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference
14 févr. 2020 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...